Impact of Cardiac Rehabilitation on Patient Outcomes
NCT07468955
Arterial Occlusive Diseases, Arteriosclerosis
Kütahya, Center, Turkey (Türkiye)
View Trial DetailsNCT Number: NCT03292055
This study aims to evaluate the psychometric properties of a newly developed FFQ specified for northern Chinese CHD and their high risk patients (CHD-FFQ). The psychometric properties include test-retest reliability, content validity, convergent validity, discriminant validity, concurrent validity and predictive validity. Particularly, this study will measure the physiological indicators, including plasma lipid profile (i.e. TG, TC, HDL-C, LDL-C), BG, BP and BMI twice at baseline and the end. The level of these physiological indicators will be compared with the fat intake measured by the CHD-FFQ, i.e. the baseline intake to test its convergent validity. It is also expected to predict the diet-related progression of CHD risks among high-risk individuals, i.e. patients with two or more CHD risk factors as following: raised fasting blood glucose (BG) level, increased blood pressure (BP), increased triglycerides (TG), decreased HDL-Cholesterol (HDL-C), increased LDL-Cholesterol (LDL-C), smoking and central obesity (International Diabetes Federation, 2015). In addition, this study will provide the FFQ's concurrent validity in assessing the intake of energy and nutrients against the CDC-FFQ. Moreover, whether the FFQ could detect the known differences in energy intake between men and women will be established for its discriminant validity.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Jinan Central Hospital, Jinan, Shandong, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: January-February, April- May, July- August, October- November
The newly developed FFQ (CHD-FFQ) will be applied to the participants to collect their dietary intake of food.
Time frame: January- February, October- November
In the beginning and the end of the study, the medical records of the participants will be refered to get the blood glucose, total cholesterol, triglycerides, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol in the past three months, in the department and the community centers.
Time frame: January-February, April- May, July- August, October- November
Participant's height will be measured to the nearest 0.5 cm, with a right-angle triangle resting on the scalp and against the wall, having the back square against the wall tape and eyes looking straight ahead. The height will be measured without wearing shoes.
Time frame: January-February, April- May, July- August, October- November
A calibrated scale with the resolution of 0.1 kg will be used to measure the weight of the participants, who will be asked to wear light clothes during measurement. The weight will be measured without shoes.
Time frame: January-February, April- May, July- August, October- November
weight and height will be combined to report BMI in kg/m^2
Time frame: January-February, April- May, July- August, October- November
Waist circumstance will be taken at the midpoint between the top of the iliac crest and the lower margin of the palpable rib
Time frame: January-February, April- May, July- August, October- November
To take the blood pressure, the participant will be asked to be seated for at least 15 minutes with his/her legs uncrossed (WHO, 2008). Two BP measurements will be taken and between the two readings, the participant will have three minutes' rest.
Time frame: October-November
As a criterion, the FFQ developed by Chinese CDC will be applied to the participants to collect their dietary intake of food.
Time frame: January-February
Age, gender, marital status, occupation, educational level, living conditions, financial background, and living areas will be collected using a self-developed questionnaire.
Time frame: January-February
Smoking history, family history and clinical data will be collected using a self-developed questionnaire.
Time frame: October- November
Their clinical information on hospital readmission, surgery or medical procedures, and medication adjustment during the last year will be collected.
Time frame: January-February, April- May, July- August, October- November
The physical activity level of the participants will be measured using the Chinese version of the short version of International Physical Activity Questionnaire (short- Chinese IPAQ).
Chinese University of Hong Kong
Other
Evaluation of the Psychometric Properties of a Food Frequency Questionnaire Developed for Patients With Coronary Heart Disease in Northern China
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07468955
Arterial Occlusive Diseases, Arteriosclerosis
Kütahya, Center, Turkey (Türkiye)
View Trial DetailsNCT05099692
Cardiac Rehabilitation, Cardiovascular Diseases
Shenyang, Liaoning, China
View Trial DetailsNCT00552591
Cardiovascular Diseases, Coronary Disease
Ottawa, Ontario, Canada
View Trial DetailsNCT04465669
Angina Pectoris, Angina, Stable
Tyumen, Russia
View Trial Details